Quantitative assessment of caffeine partial clearances in man

Area of Science:

• Pharmacology
• Metabolism Studies
• Drug Development

Background:

• Caffeine (CA) is a widely consumed stimulant with several known metabolites.
• Understanding the quantitative contribution of each metabolite is crucial for assessing CA's physiological effects and potential drug interactions.
• Previous studies have identified paraxanthine (PX), theobromine (TB), and theophylline (TP) as primary monodemethylated metabolites of CA.

Purpose of the Study:

• To precisely define the fractional conversion of caffeine (CA) to its primary metabolites: paraxanthine (PX), theobromine (TB), and theophylline (TP).
• To determine the individual partial clearances of CA for each demethylation pathway.
• To re-evaluate the quantitative importance of paraxanthine (PX) as a major human metabolite of caffeine (CA).

Main Methods:

• Utilized data from five subjects previously studied for caffeine (CA) pharmacokinetics.
• Administered CA to steady-state and analyzed plasma concentration-time curves for CA and its metabolites (PX, TB, TP).
• Integrated steady-state data with previously determined individual plasma clearances of PX, TB, and TP to calculate fractional conversion and partial clearances.

Main Results:

• The mean fractional conversion of CA to PX, TB, and TP was 79.6%, 10.8%, and 3.7%, respectively.
• Considering only demethylation pathways, PX, TB, and TP accounted for 83.9%, 12.1%, and 4.0% of CA demethylations.
• Partial clearance of CA to PX was significantly higher (8-fold and 23-fold) than to TB and TP, respectively.

Conclusions:

• Paraxanthine (PX) is confirmed as the major human metabolite of caffeine (CA).
• The formation of paraxanthine (PX) from caffeine (CA) is quantitatively more important than previously estimated.
• These findings refine our understanding of caffeine metabolism and its pharmacokinetic profile in humans.